Literature DB >> 27891352

Herbal Fixed Dose Combinations in Nepal: Growing Concerns in a Developing Country.

Arjun Poudel1, Kadir Alam2, Subish Palaian3, Mohamed Izham Mohamed Ibrahim4.   

Abstract

Herbal medicines are mostly prepared as a combination therapy that has been used since therapeutic was first practiced. Combination products, also known as Fixed Dose Combinations (FDCs) of herbal remedies are in widespread use in Nepal. Herbal FDCs are in common practice because it is believed to have better adherence, less side effects and easy accessibility. Nevertheless, combination products possess greater risk of adverse effects, increases costs associated with treatments and leads to an ineffective dosages. Herbal FDCs are used extensively in Nepal although the rationality beyond the use of these combinations is still unidentified and at times are questionable. Legislations governing the use of herbal medicines is lacking in Nepal. Many herbal FDCs are not supported by any scientific data and test for the presence of ingredients mentioned in the package insert/container label is always difficult. A FDC of herbal products must be based on clear criteria that guarantee consumer safety and appropriate indications. These criteria helps to protect the consumers or patients from the misleading claims and risk associated with the use of unjustifiable combination of herbal substances. Strict monitoring from the regulatory body and the public awareness on the cost as well as advantages and disadvantages of herbal FDCs is urgently required.

Entities:  

Keywords:  Combination therapy; Herbal medicines; Irrational drug use

Year:  2016        PMID: 27891352      PMCID: PMC5121690          DOI: 10.7860/JCDR/2016/20519.8686

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  Regulation of herbal medicines in Japan.

Authors:  H Saito
Journal:  Pharmacol Res       Date:  2000-05       Impact factor: 7.658

2.  Fixed dose drug combinations (FDCs): rational or irrational: a view point.

Authors:  Chandler S Gautam; Lekha Saha
Journal:  Br J Clin Pharmacol       Date:  2008-02-21       Impact factor: 4.335

Review 3.  Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment.

Authors:  Scott A Jordan; David G Cunningham; Robin J Marles
Journal:  Toxicol Appl Pharmacol       Date:  2009-12-16       Impact factor: 4.219

Review 4.  Irrational fixed dose combinations in Nepal: need for intervention.

Authors:  A Poudel; S Palaian; P R Shankar; J Jayasekera; M I Izham
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2008 Jul-Sep

5.  Complementary and Alternative Healthcare: Is it Evidence-based?

Authors:  Syed Amin Tabish
Journal:  Int J Health Sci (Qassim)       Date:  2008-01

Review 6.  News from Tartary: an ethnopharmacological approach to drug and therapeutic discovery.

Authors:  Nicholas Moore; Nawel Hamza; Benedicte Berke; Anwar Umar
Journal:  Br J Clin Pharmacol       Date:  2016-07-24       Impact factor: 4.335

7.  Assessment of Rationality of Fixed Dose Combinations Approved in CDSCO List.

Authors:  Krunal Dalal; Barna Ganguly; Alpa Gor
Journal:  J Clin Diagn Res       Date:  2016-04-01

8.  Analgesic use in dentistry in a tertiary hospital in western Nepal.

Authors:  Chayna Sarkar; Biswadeep Das; P Baral
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-10       Impact factor: 2.890

9.  A study of use of fixed dose combinations in Ahmedabad, India.

Authors:  Jayeshbhai Dineshchandra Balat; Anuradha M Gandhi; Prakruti P Patel; Ram K Dikshit
Journal:  Indian J Pharmacol       Date:  2014 Sep-Oct       Impact factor: 1.200

Review 10.  Compliance and fixed-dose combination therapy.

Authors:  Sripal Bangalore; Anupama Shahane; Sanobar Parkar; Franz H Messerli
Journal:  Curr Hypertens Rep       Date:  2007-06       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.